Literature DB >> 21984246

Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.

Natalie A Parlane1, Katrin Grage, Jason W Lee, Bryce M Buddle, Michel Denis, Bernd H A Rehm.   

Abstract

Vaccine delivery systems based on display of antigens on bioengineered bacterial polyester inclusions can stimulate cellular immune responses. The food-grade Gram-positive bacterium Lactococcus lactis was engineered to produce spherical polyhydroxybutyrate (PHB) inclusions which abundantly displayed the hepatitis C virus core (HCc) antigen. In mice, the immune response induced by this antigen delivery system was compared to that induced by vaccination with HCc antigen displayed on PHB beads produced in Escherichia coli, to PHB beads without antigen produced in L. lactis or E. coli, or directly to the recombinant HCc protein. Vaccination site lesions were minimal in all mice vaccinated with HCc PHB beads or recombinant protein, all mixed in the oil-in-water adjuvant Emulsigen, while vaccination with the recombinant protein in complete Freund's adjuvant produced a marked inflammatory reaction at the vaccination site. Vaccination with the PHB beads produced in L. lactis and displaying HCc antigen produced antigen-specific cellular immune responses with significant release of gamma interferon (IFN-γ) and interleukin-17A (IL-17A) from splenocyte cultures and no significant antigen-specific serum antibody, while the PHB beads displaying HCc but produced in E. coli released IFN-γ and IL-17A as well as the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and IL-6 and low levels of IgG2c antibody. In contrast, recombinant HCc antigen in Emulsigen produced a diverse cytokine response and a strong IgG1 antibody response. Overall it was shown that L. lactis can be used to produce immunogenic PHB beads displaying viral antigens, making the beads suitable for vaccination against viral infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984246      PMCID: PMC3233089          DOI: 10.1128/AEM.06420-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  50 in total

1.  Class I and III polyhydroxyalkanoate synthases from Ralstonia eutropha and Allochromatium vinosum: characterization and substrate specificity studies.

Authors:  W Yuan; Y Jia; J Tian; K D Snell; U Müh; A J Sinskey; R H Lambalot; C T Walsh; J Stubbe
Journal:  Arch Biochem Biophys       Date:  2001-10-01       Impact factor: 4.013

2.  HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant.

Authors:  Jigna Patel; David Galey; Julia Jones; Phillip Ray; Jerold G Woodward; Avi Nath; Russell J Mumper
Journal:  Vaccine       Date:  2006-02-17       Impact factor: 3.641

3.  In vivo enzyme immobilization by use of engineered polyhydroxyalkanoate synthase.

Authors:  Verena Peters; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

4.  Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.

Authors:  Qiuxiang Zhang; Jin Zhong; Liandong Huan
Journal:  Microbiol Res       Date:  2010-03-12       Impact factor: 5.415

5.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

Review 6.  Cell-mediated immunity and the outcome of hepatitis C virus infection.

Authors:  Naglaa H Shoukry; Andrew G Cawthon; Christopher M Walker
Journal:  Annu Rev Microbiol       Date:  2004       Impact factor: 15.500

7.  Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.

Authors:  Andrea Cruz; Alexandra G Fraga; Jeffrey J Fountain; Javier Rangel-Moreno; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Troy D Randall; Jorge Pedrosa; Andrea M Cooper; António G Castro
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

Review 8.  Bacterial polyhydroxyalkanoate granules: biogenesis, structure, and potential use as nano-/micro-beads in biotechnological and biomedical applications.

Authors:  Katrin Grage; Anika C Jahns; Natalie Parlane; Rajasekaran Palanisamy; Indira A Rasiah; Jane A Atwood; Bernd H A Rehm
Journal:  Biomacromolecules       Date:  2009-04-13       Impact factor: 6.988

Review 9.  Vaccine adjuvants: putting innate immunity to work.

Authors:  Robert L Coffman; Alan Sher; Robert A Seder
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

10.  Production of functionalized biopolyester granules by recombinant Lactococcus lactis.

Authors:  Jun Mifune; Katrin Grage; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2009-05-22       Impact factor: 4.792

View more
  19 in total

1.  Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.

Authors:  Natalie A Parlane; Katrin Grage; Jun Mifune; Randall J Basaraba; D Neil Wedlock; Bernd H A Rehm; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

2.  Engineering bacteria to manufacture functionalized polyester beads.

Authors:  Jenny L Draper; Bernd H Rehm
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

3.  Bioengineering of bacteria to assemble custom-made polyester affinity resins.

Authors:  Iain D Hay; Jinping Du; Natalie Burr; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2014-10-24       Impact factor: 4.792

Review 4.  Biomedical Applications of Polyhydroxyalkanoates.

Authors:  Subhasree Ray; Vipin Chandra Kalia
Journal:  Indian J Microbiol       Date:  2017-04-22       Impact factor: 2.461

5.  Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.

Authors:  G Martínez-Donato; B Piniella; D Aguilar; S Olivera; A Pérez; Y Castañedo; L Alvarez-Lajonchere; S Dueñas-Carrera; J W Lee; N Burr; M Gonzalez-Miro; B H A Rehm
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

6.  New skin test for detection of bovine tuberculosis on the basis of antigen-displaying polyester inclusions produced by recombinant Escherichia coli.

Authors:  Shuxiong Chen; Natalie A Parlane; Jason Lee; D Neil Wedlock; Bryce M Buddle; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2014-02-14       Impact factor: 4.792

7.  Expanding the recombinant protein quality in Lactococcus lactis.

Authors:  Olivia Cano-Garrido; Fabian L Rueda; Laura Sànchez-García; Luis Ruiz-Ávila; Ramon Bosser; Antonio Villaverde; Elena García-Fruitós
Journal:  Microb Cell Fact       Date:  2014-12-04       Impact factor: 5.328

8.  Subcutaneous Immunization with Recombinant Lactococcus lactis Expressing F1S1 Fusion Protein Induces Systemic and Mucosal Immune Responses in BALB/C Mice.

Authors:  Ali Torkashvand; Fariborz Bahrami; Minoo Adib; Soheila Ajdary
Journal:  Rep Biochem Mol Biol       Date:  2019-01

Review 9.  From Residues to Added-Value Bacterial Biopolymers as Nanomaterials for Biomedical Applications.

Authors:  Francisco G Blanco; Natalia Hernández; Virginia Rivero-Buceta; Beatriz Maestro; Jesús M Sanz; Aránzazu Mato; Ana M Hernández-Arriaga; M Auxiliadora Prieto
Journal:  Nanomaterials (Basel)       Date:  2021-06-04       Impact factor: 5.076

Review 10.  Immunopotentiating and Delivery Systems for HCV Vaccines.

Authors:  Alexander K Andrianov; Thomas R Fuerst
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.